UK markets open in 4 hours 26 minutes
NIKKEI 225
38,636.40 -67.11 (-0.17%) HANG SENG
18,431.70 -45.10 (-0.24%) CRUDE OIL
75.55 0.00 (0.00%) GOLD FUTURES
2,389.70 -1.20 (-0.05%) DOW
38,886.17 +78.84 (+0.20%) Bitcoin GBP
55,324.36 -363.42 (-0.65%)
Connect Biopharma Holdings Limited (CNTB)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 90.37M |
| Enterprise value | -27.82M |
| Trailing P/E | N/A |
| Forward P/E | 1.01 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.89 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.19 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.35 |
| 52-week change 3 | 50.46% |
| S&P500 52-week change 3 | 24.52% |
| 52-week high 3 | 2.8400 |
| 52-week low 3 | 0.5350 |
| 50-day moving average 3 | 1.6642 |
| 200-day moving average 3 | 1.2523 |
Share statistics
| Avg vol (3-month) 3 | 117.4k |
| Avg vol (10-day) 3 | 37.15k |
| Shares outstanding 5 | 55.1M |
| Implied shares outstanding 6 | 55.1M |
| Float 8 | 16.05M |
| % held by insiders 1 | 41.27% |
| % held by institutions 1 | 43.81% |
| Shares short (15 May 2024) 4 | 54.14k |
| Short ratio (15 May 2024) 4 | 0.69 |
| Short % of float (15 May 2024) 4 | 0.17% |
| Short % of shares outstanding (15 May 2024) 4 | 0.10% |
| Shares short (prior month 15 Apr 2024) 4 | 83.14k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -27.07% |
| Return on equity (ttm) | -46.03% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -64.23M |
| Net income avi to common (ttm) | -59.5M |
| Diluted EPS (ttm) | -1.0800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 118.7M |
| Total cash per share (mrq) | 2.15 |
| Total debt (mrq) | 465k |
| Total debt/equity (mrq) | 0.46% |
| Current ratio (mrq) | 4.99 |
| Book value per share (mrq) | 1.83 |
Cash flow statement
| Operating cash flow (ttm) | -47.93M |
| Levered free cash flow (ttm) | -27.07M |
© 2024 Yahoo. All rights reserved.